Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia.

J Clin Med · 2024 · PMC11312559 · PMID 39124629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally non-significantno p-value reported

The remimazolam group may have a reduced length of stay when compared to the propofol group; however, this is based on a marginally non-significant linear regression result, −0.5 days (95% CI, −1.02 to 0.02).

also in 1,493 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.